Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04325906 · ClinicalTrials.gov registry record · NA

Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS

A NA study of Acute Respiratory Distress Syndrome and Corona Virus Infection, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT04325906 is a NA study of Acute Respiratory Distress Syndrome and Corona Virus Infection that has completed, run by Rush University Medical Center. The registered enrollment target is 224 participants, below the 360-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04325906, a NA study of Acute Respiratory Distress Syndrome and Corona Virus Infection, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and had subsequently spread worldwide. Twenty-nine percent of COVID-19 patients may develop ARDS. Based on the potential beneficial mechanisms of HFNC and PP, whether early use of prone positioning combined with HFNC can avoid the need for intubation in COVID-19 induced moderate to severe ARDS patients needs to be further investigated.

Interventions

  • DEVICE high flow nasal cannula (HFNC)
  • PROCEDURE Prone positioning (PP)

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2020-04-02
Est. Completion 2021-02-21
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT04325906

The ClinicalTrials.gov registry entry for NCT04325906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 360-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (38% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Acute Respiratory Distress Syndrome appearing as the primary indexed condition, and to 2 interventions - of which high flow nasal cannula (HFNC) is the first listed.

NCT04325906 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04325906 about?

NCT04325906 is a clinical study titled "Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS". Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that was first reported in Wuhan, China, and had subsequently spread worldwide. Twenty-nine percent of COVID-19 patients may develop ARDS. Based on the potential beneficial mechanisms of HFNC and PP, whether early use of prone pos...

What is the current status of trial NCT04325906?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2020-04-02. Estimated completion is 2021-02-21.

What conditions does trial NCT04325906 study?

This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome, Corona Virus Infection, Prone Positioning, High Flow Nasal Cannula.

What interventions are being tested in trial NCT04325906?

The interventions under investigation include: high flow nasal cannula (HFNC) (DEVICE), Prone positioning (PP) (PROCEDURE).

Who is sponsoring clinical trial NCT04325906?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04325906 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Distress Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.